2001
DOI: 10.1007/bf02234796
|View full text |Cite
|
Sign up to set email alerts
|

Local excision of rectal cancer

Abstract: Local excision for rectal cancers is associated with a low morbidity and provides satisfactory local control and disease-free survival rates for T1 rectal cancers. There is, however, a need for a randomized, controlled trial for T2 cancers, comparing local excision with adjuvant chemoradiotherapy to radical resection.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

6
178
1
24

Year Published

2006
2006
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 242 publications
(209 citation statements)
references
References 116 publications
6
178
1
24
Order By: Relevance
“…62,102 High rates of local recurrence for T2 (up to 50%) and T3 tumours (up to 100%) with conventional local excision alone have been reported. [102][103][104][105][106][107][108][109] Transanal endoscopic microsurgery alone is not a reasonable treatment for fit patients who have rectal cancer that is local stage T2 or deeper. There is recent data to guide the use of TEM in patients with T2 and T3 rectal cancers.…”
Section: Advanced Rectal Adenocarcinomasmentioning
confidence: 99%
“…62,102 High rates of local recurrence for T2 (up to 50%) and T3 tumours (up to 100%) with conventional local excision alone have been reported. [102][103][104][105][106][107][108][109] Transanal endoscopic microsurgery alone is not a reasonable treatment for fit patients who have rectal cancer that is local stage T2 or deeper. There is recent data to guide the use of TEM in patients with T2 and T3 rectal cancers.…”
Section: Advanced Rectal Adenocarcinomasmentioning
confidence: 99%
“…This is expected, since the risk of lymph node involvement for T2 and T3 rectal adenocarcinomas is high (12%-28% and 36%-79%, respectively 22,32,35 ). Concerning T2 lesions, Lee, et al 21 compared patients with T1N0M0 and T2N0M0 rectal adenocarcinomas treated by TEM alone (74 patients) or by radical surgery (100 patients).…”
Section: Locally Advanced Rectal Cancersmentioning
confidence: 89%
“…However, patients have to experience long operative time and are exposed to postoperative complications such as bleeding, suture dehiscence, temporary or definitive colostomy, sexual or urinary dysfunctions, pneumonia and thromboembolic events. In this context, TEM appeared as an attractive alternative, however precise preoperative staging is imperative since the procedure does not remove all perirectal lymph nodes (the risk of its involvement is 0%-12% for T1 cancers, 12%-28% for T2 cancers, 36%-79% for T3 cancers 25,32,35 ). Therefore, local recurrence is a major concern and careful patient selection is mandatory to optimize results.…”
Section: Malignant Lesionsmentioning
confidence: 99%
“…Other additional criteria are tumour size less than 4 cm and well-or moderately well-differentiated histology. The probability of lymph node metastases for a T1 G1 (well-differentiated) tumour is around 0% compared with more than 10% for a T1 G3 (poorly differentiated) tumour [136].…”
Section: 9% [Consensus])mentioning
confidence: 98%